Dynamic BH3 profiling method for rapid identification of active therapy in BH3 mimetics resistant xenograft mouse models

The clinical effectiveness of BH3 mimetics therapy is limited by the inevitable emergence of acquired resistance. We present a protocol to model in vivo acquired resistance to BH3 mimetics in patient-derived xenograft (PDX) mouse models of acute myeloid leukemia. Using resistant PDXs as a valuable m...

Descripción completa

Detalles Bibliográficos
Autores principales: Olesinski, Elyse A., Bhatt, Shruti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131978/
https://www.ncbi.nlm.nih.gov/pubmed/34027474
http://dx.doi.org/10.1016/j.xpro.2021.100461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131978/
https://www.ncbi.nlm.nih.gov/pubmed/34027474
http://dx.doi.org/10.1016/j.xpro.2021.100461

Ejemplares similares